Sort
15,842 grants matching “pancreatic cancer”
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment
$452,960Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2015 · CA
Becton Dickinson Flow Cytometry System
$452,749University Of Illinois At Chicago · S10 · FY2002 · RR
Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
$452,729Sarah H. Elsea · Baylor College Of Medicine · R01 · FY2021 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$452,707Murray Korc · Dartmouth College · R37 · FY2010 · CA
Repurposing Disulfiram: A Novel Strategy to Help Cancer Patients Regain Muscle
$452,547Aminah Jatoi · Mayo Clinic Rochester · R01 · FY2019 · CA
Palliative Care: Maximizing Patient Preference
$452,406Donald H Taylor · Duke University · R01 · FY2010 · HS
The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center
$452,394Philip A. Hart · Ohio State University · U01 · FY2023 · DK
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$452,330Matthew J Lazzara · University Of Virginia · U01 · FY2023 · CA
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$452,330Matthew J Lazzara · University Of Virginia · U01 · FY2022 · CA
Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer
$452,316Ashok K Saluja · University Of Minnesota · R01 · FY2013 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$452,277Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$452,277Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$452,195Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2015 · CA
Discovery and Development of Cancer Glycomarkers
$452,180James Michael Pierce · University Of Georgia · U01 · FY2016 · CA
Epigenetic drivers of cancer progression
$452,149Andrew P Feinberg · Johns Hopkins University · R01 · FY2018 · CA
Basis for Lymphomagenesis in Akt2 Transgenic Mice
$452,084Joseph Robert Testa · Fox Chase Cancer Center · R01 · FY2010 · CA
FUNCTIONAL GENOMIC IDENTIFICATION AND CHARACTERIZATION OF THERAPEUTIC TARGETS
$452,039Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Biomedical Computing Tools for Pancreatic Cancer Res.
$452,026Simon Sherman · University Of Nebraska Medical Center · R33 · FY2007 · CA
Multi-modal129 Xe Probes for Tumor Detection
$451,914Ivan Julian Dmochowski · University Of Pennsylvania · R33 · FY2008 · CA
Biomarkers for the Early Detection of Pancreatic Cancer
$451,884University Of Texas Md Anderson Can Ctr · U01 · FY2004 · CA
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINS
$451,831State University New York Stony Brook · R37 · FY2003 · CA
A stress inducible Pdx1 transcriptional complex governing beta cell survival
$451,633Doris A. Stoffers · University Of Pennsylvania · R01 · FY2021 · DK
A stress inducible Pdx1 transcriptional complex governing beta cell survival
$451,633Doris A. Stoffers · University Of Pennsylvania · R01 · FY2023 · DK
A stress inducible Pdx1 transcriptional complex governing beta cell survival
$451,633Doris A. Stoffers · University Of Pennsylvania · R01 · FY2022 · DK
A stress inducible Pdx1 transcriptional complex governing beta cell survival
$451,633Doris A. Stoffers · University Of Pennsylvania · R01 · FY2019 · DK